alendronic acid
Recently Published Documents


TOTAL DOCUMENTS

725
(FIVE YEARS 137)

H-INDEX

11
(FIVE YEARS 3)

2022 ◽  
pp. 70-71
Author(s):  
Anton C. de Groot
Keyword(s):  

2022 ◽  
Vol 1888 (1) ◽  
pp. 24-24
Keyword(s):  

2021 ◽  
Vol 1885 (1) ◽  
pp. 37-37
Keyword(s):  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Kristian Kniha ◽  
Eva Miriam Buhl ◽  
Stephan Christian Möhlhenrich ◽  
Anna Bock ◽  
Frank Hölzle ◽  
...  

Abstract Background The aim of the present study was to assess the development of bacterial deposits and morphological parameters around dental zirconia and titanium implants compared with natural teeth during systemic bisphosphonate medication. Materials and methods Fifty-four rats were randomly allocated into one control group and two experimental groups (drug application of zoledronic and alendronic acid), with 18 animals in each group. After 4 weeks of drug delivery, either a zirconia or a titanium implant was immediately inserted. Microbiological analysis conducted 1 week, 8 weeks, and 12 weeks after surgery included total bacterial count and composition measurements. Samples were analyzed in a scanning electron microscope (SEM) equipped with energy-dispersive X-ray spectroscopy (EDX). Bone cell morphology was analyzed by transmission electron microscopy (TEM). Results One week after surgery, titanium and zirconia implants of the alendronic acid and control group showed a significantly higher bacterial count when compared to natural teeth in rats with zoledronic acid administration (p < 0.01). Less significant differences were recorded after 3 months, at which time no inter-material differences were evaluated (p > 0.05). I n the control group, TEM analysis showed that the osteoblasts had a strongly developed endoplasmic reticulum. In contrast, the endoplasmic reticulum of the osteoblasts in drug-treated animals was significantly less developed, indicating less activity. Conclusions Within the limits of this study, neither implant material was superior to the other at 3-month follow-up. With regard to the treatment and complications of patients with bisphosphonates, the implant material should not be an influencing factor. Bisphosphonates can be used in the rat model to reduce not only the activity of osteoclasts but also osteoblasts of the peri-implant bone.


2021 ◽  
Vol 1882 (1) ◽  
pp. 36-36
Keyword(s):  

2021 ◽  
Vol 1882 (1) ◽  
pp. 35-35
Keyword(s):  

2021 ◽  
Vol 3 (10) ◽  
pp. 386-386
Author(s):  
Sharon Rees
Keyword(s):  

In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #alendronic


Sign in / Sign up

Export Citation Format

Share Document